Ferring Pharmaceuticals

Royalty Pharma to Pay Potential $500M for Royalties on Ferring’s Gene Therapy
Royalty Pharma to Pay Potential $500M for Royalties on Ferring’s Gene Therapy
BioSpace
Ferring Pharmaceuticals
Royalty Pharma
gene therapy
bladder cancer
Flag link:
Ferring, with manufacturing update, takes a step towards first gene therapy sales
Ferring, with manufacturing update, takes a step towards first gene therapy sales
BioPharma Dive
Ferring Pharmaceuticals
FDA
bladder cancer
gene therapy
Adstiladrin
Flag link:
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Flag link:
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Flag link:
Go or no go? Seagen's Padcev eyes FDA approval
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
Flag link:
Ferring shuts down U.S.-based research institute after more than 25 years, cutting nearly 90 employees
Ferring shuts down U.S.-based research institute after more than 25 years, cutting nearly 90 employees
Fierce Biotech
Ferring Pharmaceuticals
San Diego
California
layoffs
Flag link:
A renewed push into early bladder cancer
A renewed push into early bladder cancer
EP Vantage
Ferring Pharmaceuticals
Adstiladrin
FDA
gene therapy
bladder cancer
Flag link:
Ferring wins FDA approval for bladder cancer gene therapy
Ferring wins FDA approval for bladder cancer gene therapy
BioPharma Dive
Ferring Pharmaceuticals
bladder cancer
gene therapy
FDA
Adstiladrin
Flag link:
This Week at FDA: FDA approves first FMT product, upcoming mpox guidance, and more
This Week at FDA: FDA approves first FMT product, upcoming mpox guidance, and more
RAPS.org
FDA
regulatory
mpox
Ferring Pharmaceuticals
microbiome
COVID-19
Eli Lilly
Flag link:
FDA approves first fecal microbiome drug, setting stage for others
FDA approves first fecal microbiome drug, setting stage for others
Stat
Ferring Pharmaceuticals
Rebyota
FDA
C. difficile
fecal microbiome
microbiome
Flag link:
FDA panel recommends Ferring's fecal transplant therapy
FDA panel recommends Ferring's fecal transplant therapy
NASDAQ
Ferring Pharmaceuticals
fecal transplants
C. difficile
FDA
Flag link:
Go or no go? Bristol’s Tyk2 test
Go or no go? Bristol’s Tyk2 test
EP Vantage
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides
Flag link:
FDA's vaccine adcomm to review first fecal transplant to treat C. difficile infections
FDA's vaccine adcomm to review first fecal transplant to treat C. difficile infections
Endpoints
FDA
Ferring Pharmaceuticals
Rebiotix
RBX2660
C. difficile
Flag link:
The year the regulators meet the microbiome
The year the regulators meet the microbiome
EP Vantage
microbiome
Seres Therapeutics
Ferring Pharmaceuticals
FDA
C. difficile
Flag link:
Ferring’s gut microbiome drug clears phase 3 trial in C. diff
Ferring’s gut microbiome drug clears phase 3 trial in C. diff
Pharmaforum
Ferring Pharmaceuticals
clinical trials
microbiome
C. difficile
RBX2660
Flag link:
FerGene’s Bladder Cancer Phase III Trial Hits Its Mark
FerGene’s Bladder Cancer Phase III Trial Hits Its Mark
BioSpace
FerGene
gene therapy
bladder cancer
NMIBC
Ferring Pharmaceuticals
Blackstone Life Sciences
clinical trials
Flag link: